Does Taking a Daily Multivitamin Slow Biological Aging?
A recent study suggests that a daily multivitamin may slow biological aging by about four months over a two-year period. This finding raises important questions about the potential health benefits of multivitamins, particularly as they relate to aging and longevity.
The study, published in Nature Medicine, analyzed DNA methylation data from blood samples of 958 participants, who had an average chronological age of 70. Participants were randomized into four groups: one receiving a multivitamin and cocoa extract, another receiving cocoa extract and a placebo, a third receiving a multivitamin and a placebo, and the last group receiving two placebos. The results showed statistically significant slowing in two epigenetic clocks predictive of mortality.
Howard Sesso, a researcher involved in the study, expressed enthusiasm about the results, stating, “It was exciting to see the benefits of a multivitamin linked with markers of biological aging.” The research was funded by the National Institutes of Health, underscoring its significance in the field of health and aging.
Interestingly, the study found that those who were biologically older than their actual age benefited the most from multivitamin supplementation. This suggests that multivitamins may have a more pronounced effect on individuals whose biological aging is accelerated compared to their chronological age.
Epigenetic clocks, which estimate biological aging based on changes in DNA methylation, have become a valuable tool in understanding the aging process. The findings from this study contribute to a growing body of evidence that highlights the potential of accessible and safe interventions, like multivitamins, to promote healthier and higher-quality aging.
However, details remain unconfirmed regarding the clinical relevance of these findings. While the study indicates a potential benefit, it is still unclear who specifically may benefit from multivitamin supplementation. Sesso noted, “Ultimately, it is critical to determine the clinical relevance of our findings,” emphasizing the need for further research.
Additionally, Sesso reassured that there are no known risks associated with taking a multivitamin in the context of their two large clinical trials, stating, “A lot of people take a multivitamin without necessarily knowing any benefits from taking it, so the more we can learn about its potential health benefits, the better.” This highlights the importance of ongoing research in this area to better understand the implications of multivitamin use for aging and overall health.
